These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33222177)

  • 1. Retrospective validation study of miniPIERS prediction model in Zanzibar.
    van der Meij E; Herklots T; Yussuf S; Meguid T; Franx A; Payne BA; Jacod B
    Int J Gynaecol Obstet; 2021 May; 153(2):300-306. PubMed ID: 33222177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study.
    Payne BA; Hutcheon JA; Ansermino JM; Hall DR; Bhutta ZA; Bhutta SZ; Biryabarema C; Grobman WA; Groen H; Haniff F; Li J; Magee LA; Merialdi M; Nakimuli A; Qu Z; Sikandar R; Sass N; Sawchuck D; Steyn DW; Widmer M; Zhou J; von Dadelszen P;
    PLoS Med; 2014 Jan; 11(1):e1001589. PubMed ID: 24465185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the incremental value of blood oxygen saturation (SpO(2)) in the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) Risk Prediction Model.
    Payne BA; Hutcheon JA; Dunsmuir D; Cloete G; Dumont G; Hall D; Lim J; Magee LA; Sikandar R; Qureshi R; Papendorp EV; Mark Ansermino J; Dadelszen PV
    J Obstet Gynaecol Can; 2015 Jan; 37(1):16-24. PubMed ID: 25764032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and internal validation of a multivariable model to predict perinatal death in pregnancy hypertension.
    Payne BA; Groen H; Ukah UV; Ansermino JM; Bhutta Z; Grobman W; Hall DR; Hutcheon JA; Magee LA; von Dadelszen P;
    Pregnancy Hypertens; 2015 Oct; 5(4):315-21. PubMed ID: 26597747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of competing-risks model in screening for pre-eclampsia in twin pregnancy by maternal factors.
    Benkő Z; Chaveeva P; de Paco Matallana C; Zingler E; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 May; 53(5):649-654. PubMed ID: 30887621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation of a simple risk score based on the ASPRE trial algorithm for preterm pre-eclampsia considering maternal characteristics in nulliparous pregnant women: a multicentre retrospective cohort study.
    Brunelli E; Seidenari A; Germano C; Prefumo F; Cavoretto P; Di Martino D; Masturzo B; Morano D; Rizzo N; Farina A
    BJOG; 2020 Sep; 127(10):1210-1215. PubMed ID: 32275798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revised competing-risks model in screening for pre-eclampsia in twin pregnancy by maternal characteristics and medical history.
    Benkő Z; Chaveeva P; de Paco Matallana C; Zingler E; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Nov; 54(5):617-624. PubMed ID: 31364214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive performance of the competing risk model in screening for preeclampsia.
    Wright D; Tan MY; O'Gorman N; Poon LC; Syngelaki A; Wright A; Nicolaides KH
    Am J Obstet Gynecol; 2019 Feb; 220(2):199.e1-199.e13. PubMed ID: 30447210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic review.
    Ukah UV; De Silva DA; Payne B; Magee LA; Hutcheon JA; Brown H; Ansermino JM; Lee T; von Dadelszen P
    Pregnancy Hypertens; 2018 Jan; 11():115-123. PubMed ID: 29198742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External Validation of the fullPIERS Model for Predicting Adverse Maternal Outcomes in Pregnancy Hypertension in Low- and Middle-Income Countries.
    Ukah UV; Payne B; Lee T; Magee LA; von Dadelszen P;
    Hypertension; 2017 Apr; 69(4):705-711. PubMed ID: 28167685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal and external validation of the fullPIERS model for the prediction of adverse maternal outcomes in women with pre-eclampsia.
    Ukah UV; Payne B; Karjalainen H; Kortelainen E; Seed PT; Conti-Ramsden FI; Cao V; Laivuori H; Hutcheon J; Chappell L; Mark Ansermino J; Vatish M; Redman C; Lee T; Li L; Magee LA; von Dadelszen P;
    Pregnancy Hypertens; 2019 Jan; 15():42-50. PubMed ID: 30825926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting complications in pre-eclampsia: external validation of the fullPIERS model using the PETRA trial dataset.
    Akkermans J; Payne B; von Dadelszen P; Groen H; Vries Jd; Magee LA; Mol BW; Ganzevoort W
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():58-62. PubMed ID: 24965981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of locally tailored clinical guidelines on intrapartum management of severe hypertensive disorders at Zanzibar's tertiary hospital (the PartoMa study).
    Maaløe N; Andersen CB; Housseine N; Meguid T; Bygbjerg IC; van Roosmalen J
    Int J Gynaecol Obstet; 2019 Jan; 144(1):27-36. PubMed ID: 30307609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors associated with severe pre-eclampsia among postpartum women in Zanzibar: a cross-sectional study.
    Machano MM; Joho AA
    BMC Public Health; 2020 Sep; 20(1):1347. PubMed ID: 32887579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe maternal morbidity in Zanzibar's referral hospital: Measuring the impact of in-hospital care.
    Herklots T; van Acht L; Meguid T; Franx A; Jacod B
    PLoS One; 2017; 12(8):e0181470. PubMed ID: 28832665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [External validation of FullPIERS model for prediction of adverse outcomes among women with pre-eclampsia in French maternity of 2014 to 2018].
    Boutot M; Margueritte F; Boukeffa N; Coste Mazeau P; Aubard Y; Gauthier T
    Gynecol Obstet Fertil Senol; 2020 Feb; 48(2):167-173. PubMed ID: 31923643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta-analysis.
    Bernardes TP; Zwertbroek EF; Broekhuijsen K; Koopmans C; Boers K; Owens M; Thornton J; van Pampus MG; Scherjon SA; Wallace K; Langenveld J; van den Berg PP; Franssen MTM; Mol BWJ; Groen H
    Ultrasound Obstet Gynecol; 2019 Apr; 53(4):443-453. PubMed ID: 30697855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study.
    Myers JE; Kenny LC; McCowan LM; Chan EH; Dekker GA; Poston L; Simpson NA; North RA;
    BJOG; 2013 Sep; 120(10):1215-23. PubMed ID: 23906160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of WHO's near-miss approach in a high maternal mortality setting.
    Herklots T; van Acht L; Khamis RS; Meguid T; Franx A; Jacod B
    PLoS One; 2019; 14(5):e0217135. PubMed ID: 31095635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Internal Validation of a Model Predicting Premature Cardiovascular Disease Among Women With Hypertensive Disorders of Pregnancy: A Population-Based Study in Quebec, Canada.
    Ukah UV; Dayan N; Auger N; He S; Platt RW
    J Am Heart Assoc; 2020 Oct; 9(20):e017328. PubMed ID: 33054502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.